MSc LLM - Annexin Pharmaceuticals Therapy Ophthalmology
ANNX Stock | SEK 0.31 0.01 3.33% |
Insider
MSc LLM is Therapy Ophthalmology of Annexin Pharmaceuticals AB
Phone | 46 7 09 65 16 65 |
Web | https://www.annexinpharma.com/sv |
Annexin Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (0.568) % which means that it has lost $0.568 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0595) %, meaning that it generated substantial loss on money invested by shareholders. Annexin Pharmaceuticals' management efficiency ratios could be used to measure how well Annexin Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 14 records | INSIDER Age | ||
Gunilla Osswald | BioArctic AB | 62 | |
Mathias Skalmstad | Sprint Bioscience AB | N/A | |
Johanna Flting | BioArctic AB | 51 | |
Frida Lekander | BioArctic AB | N/A | |
Christer Mller | BioArctic AB | 64 | |
Oskar Bosson | BioArctic AB | 47 | |
Gunilla Andersson | BioArctic AB | 62 | |
Prof MBA | Sprint Bioscience AB | 64 | |
Jan Mattsson | BioArctic AB | 63 | |
Fredrik Carling | Veg of Lund | 52 | |
Eva Tornberg | Veg of Lund | 75 | |
Pr Gellerfors | BioArctic AB | 76 | |
Harald Borgeke | BioArctic AB | N/A | |
Pr Lannfelt | BioArctic AB | 74 |
Management Performance
Return On Equity | -1.06 | |||
Return On Asset | -0.57 |
Annexin Pharmaceuticals Leadership Team
Elected by the shareholders, the Annexin Pharmaceuticals' board of directors comprises two types of representatives: Annexin Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Annexin. The board's role is to monitor Annexin Pharmaceuticals' management team and ensure that shareholders' interests are well served. Annexin Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Annexin Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Ulrika Harndahl, Head CMC | ||
Anna MD, Chief Officer | ||
Susan Suchdev, Chief Officer | ||
Henrik Palm, Chief Officer | ||
Anders MD, Chief Officer | ||
MSc LLM, Therapy Ophthalmology |
Annexin Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Annexin Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.06 | |||
Return On Asset | -0.57 | |||
Current Valuation | 125.48 M | |||
Shares Outstanding | 154.5 M | |||
Shares Owned By Insiders | 45.17 % | |||
Shares Owned By Institutions | 5.06 % | |||
Price To Book | 4.90 X | |||
EBITDA | (50.28 M) | |||
Net Income | (52.14 M) | |||
Cash And Equivalents | 22.77 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Annexin Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Annexin Pharmaceuticals' short interest history, or implied volatility extrapolated from Annexin Pharmaceuticals options trading.
Pair Trading with Annexin Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annexin Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexin Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Annexin Stock
0.58 | VITR | Vitrolife AB | PairCorr |
0.41 | NANOFS | Nanoform Finland Plc | PairCorr |
The ability to find closely correlated positions to Annexin Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Annexin Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Annexin Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Annexin Pharmaceuticals AB to buy it.
The correlation of Annexin Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Annexin Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Annexin Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Annexin Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annexin Pharmaceuticals AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Annexin Stock analysis
When running Annexin Pharmaceuticals' price analysis, check to measure Annexin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexin Pharmaceuticals is operating at the current time. Most of Annexin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Annexin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Annexin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |